A Randomized Controlled Trial on Prophylactic Platelet Transfusion Prior to Central Venous Catheter Placement in Patients with Thrombocytopenia
- Conditions
- Low platelet CountPlatelet deficiency100355341006988810025309
- Registration Number
- NL-OMON50641
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 392
1. Age>18 years
2. Need for CVC placement at the clinician*s discretion
3. Platelet count between 10*50x109/L
4. INR*3.0
5. Informed consent
1. Use of therapeutic anticoagulant therapy, except single antiplatelet therapy
2. Contra-indication for PC transfusion, such Thrombotic thrombocytopenic
purpura, or Congenital IgA deficiency.
3. Randomization in the current trial, in the previous 24 hours.
4. Patients with a history of congenital or acquired coagulation factor
deficiency or bleeding diathesis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome of this study will be a procedure-related relevant<br /><br>bleeding, occurring within 24 hours after the procedure. A WHO grade 2-4 up to<br /><br>24 hours of randomization is defined as relevant bleeding. Based on<br /><br>observational studies we expect mainly grade 2 bleeding and no grade 3-4<br /><br>bleeding. It should be noted that clinical relevance of a grade 2 bleeding is<br /><br>still relatively low. An assessment of bleeding will be standardized and<br /><br>performed by an independent research physician blinded to the transfusion<br /><br>strategy 1 and 24 hours after the procedure and when clinically indicated. </p><br>
- Secondary Outcome Measures
Name Time Method <p>- WHO grade 1 bleeding within 24 hours of CVC placement<br /><br>- allergic transfusion reaction within 24 hours<br /><br>- onset of acute lung injury within 48 hours.<br /><br>- length of hospital stay<br /><br>- number of RBCs and PC transfusions within 24 hours<br /><br>- costs<br /><br>Hemoglobin and platelet count will be measured at 1 and 24 hours after the<br /><br>procedure and when clinically indicated. </p><br>